Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Uncover effective ways to save money quickly. These strategies will help you enhance your financial situation in no time.
18,921 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A prominent investor labels SpaceX’s lofty value as bubblicious, arguing that Starlink’s progress alone may not justi...
Mortgage rates in early 2026 show a pause after a volatile fall and rise. This piece breaks down what buyers and inve...
Nike just 11-year low signals a pivotal moment for the brand and its investors. This article breaks down what's weigh...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Ready to make rental properties a real pathway to retirement? This guide outlines three actionable strategies for 202...
The memory market is cyclical, and July 10 could bring a stock-moving catalyst for Micron. This guide breaks down why...
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
AI data centers are driving a new energy challenge as grid bottlenecks stall growth. Off-grid, flameless generators a...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
June data show manufacturing activity extended its six-month expansion, signaling resilience amid tariffs and inflati...